logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Progestin-containing Intrauterine System class drugs

    FiltersReset Filters
    8 results

    • balcoltra

      (levonorgestrel and ethinyl estradiol)
      Avion Pharmaceuticals
      Usage: Balcoltra is indicated for use in females of reproductive potential for the prevention of pregnancy.

    • climara pro

      (Estradiol and Levonorgestrel)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: Climara Pro is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis, specifically in women at significant risk. Non-estrogen medications should be considered first for osteoporosis prevention.

    • kyleena

      (Levonorgestrel)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: Kyleena is indicated for the prevention of pregnancy for up to 5 years. If continued use is desired, the device should be replaced after 5 years.

    • liletta

      (Levonorgestrel)
      Allergan, Inc.
      Usage: LILETTA is indicated for contraception to prevent pregnancy for up to 8 years and for the treatment of heavy menstrual bleeding for up to 5 years in patients using intrauterine contraception, with replacement required after 5 years if continued treatment is necessary.

    • mirena

      (Levonorgestrel)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: Mirena is indicated for contraception, preventing pregnancy for up to 8 years, and for treating heavy menstrual bleeding for up to 5 years in women using it as their contraceptive method. Replacement is suggested at the end of the respective durations if treatment continues.

    • skyla

      (Levonorgestrel)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: Skyla® is indicated for the prevention of pregnancy for up to 3 years. If continued use is desired, the system should be replaced after this duration.

    • twirla

      (levonorgestrel/ethinyl estradiol)
      Agile Therapeutics, Inc.
      Usage: TWIRLA is indicated for contraception in women of reproductive potential with a BMI < 30 kg/m². However, caution is advised for those with a BMI ≥ 25 to < 30 kg/m² due to reduced effectiveness, and it is contraindicated for women with a BMI ≥ 30 kg/m².

    • tyblume

      (Levonorgestrel and Ethinyl Estradiol)
      Exeltis USA, Inc.
      Usage: TYBLUME is indicated for females of reproductive potential to prevent pregnancy.